We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

14 hedge funds and large institutions have $19.4M invested in Biolase, Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

166% more capital invested

Capital invested by funds: $7.28M → $19.4M (+$12.1M)

22% less funds holding

Funds holding: 18 → 14 (-4)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
14
Holders Change
-4
Holders Change %
-22.22%
% of All Funds
0.3%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
–
Increased
5
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
Archon Capital Management
Washington
+$1.58M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$72.9K
3
Northern Trust
Northern Trust
Illinois
+$9.71K
4
UBS Group
UBS Group
Switzerland
+$9.71K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.86K

Top Sellers

Rank Fund Capital Flow
1
TMC
Trellus Management Company
Florida
-$53.4K
2
Citadel Advisors
Citadel Advisors
Florida
-$13K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$13K
4
TSS
Two Sigma Securities
New York
-$12K
5
IA
IFP Advisors
Florida
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
OIM
1
Oracle Investment Management
Connecticut
$14.7M – – –
ACM
2
Archon Capital Management
Washington
$2.93M +$1.58M +326 +196%
BlackRock
3
BlackRock
New York
$688K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$388K +$72.9K +15 +30%
TMC
5
Trellus Management Company
Florida
$277K -$53.4K -11 -19%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$110K +$4.86K +1 +6%
Northern Trust
7
Northern Trust
Illinois
$86K +$9.71K +2 +17%
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$80K – – –
TA
9
Teton Advisors
New York
$52K – – –
Bank of New York Mellon
10
Bank of New York Mellon
New York
$26K – – –
UBS Group
11
UBS Group
Switzerland
$25K +$9.71K +2 +100%
Morgan Stanley
12
Morgan Stanley
New York
$23K – – –
TFO
13
Tarbox Family Office
California
$19K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$8K – – –
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$1K – – –
APA
17
American Portfolios Advisors
New York
$971 – – –
Citadel Advisors
18
Citadel Advisors
Florida
– -$13K -5 Closed
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
– -$13K -5 Closed
TSS
20
Two Sigma Securities
New York
– -$12K -5 Closed
IA
21
IFP Advisors
Florida
– -$2K -1 Closed

BIOL Hedge Fund Activity: Q1 2019 in Review

14 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q1 2019, worth a combined $19.4M — up 166% from $7.28M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BIOL and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 5 added.

The largest buyer was Archon Capital Management, adding an estimated $1.58M. The largest seller was Trellus Management Company, cutting an estimated $53.4K.

  • 14 institutional investors held Biolase, Inc. (BIOL) as of Q1 2019, down from 18 in Q4 2018.
  • Funds reported $19.4M of Biolase, Inc. stock for Q1 2019, up 166% quarter-over-quarter.
  • 0 funds opened new Biolase, Inc. positions in Q1 2019 and 4 closed out, a net change of -4 holders.
  • The largest Biolase, Inc. buyer in Q1 2019 was Archon Capital Management, an estimated $1.58M added.
  • The largest Biolase, Inc. seller in Q1 2019 was Trellus Management Company, an estimated $53.4K sold.

Based on aggregated 13F filings for Q1 2019.